Workplace Drug Testing Laws — Federal & State Overview
Cannabis workplace drug testing in the United States sits at the intersection of federal prohibition, state legalization, and a rapidly evolving body of employment law. This page is the master map of that landscape.
The Short Version
Federal rules (SAMHSA, DOT, Drug-Free Workplace Act) treat cannabis as a prohibited Schedule I drug regardless of state law. Approximately 15 states now provide off-duty cannabis use protections for workers. Another 6–9 states protect only medical cannabis cardholders. The remaining states provide no employment protection at all. Your location determines your rights.
The Core Tension
Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act. This means:
- Federal employers treat cannabis use as prohibited
- Federal contractors must maintain drug-free workplace programs
- DOT-regulated workers (CDL drivers, pilots, etc.) are subject to federal testing rules
- The ADA explicitly excludes cannabis users from disability protection
- Federal security clearances treat cannabis use as a disqualifying factor
At the same time, a growing number of states have enacted protections that limit what private employers can do with a positive cannabis drug test. These protections take several forms:
- Off-duty use statutes (California, New York, New Jersey, Washington, Minnesota, Montana, Maine, Rhode Island, Connecticut, Illinois, D.C.)
- Medical cannabis accommodation statutes (Arizona, Arkansas, Delaware, Oklahoma, Pennsylvania, West Virginia, and others)
- Pre-employment testing restrictions (Nevada, New York City, Philadelphia, Portland OR, Washington State as of 2024)
- Drug-free workplace law modifications (Minnesota's DATWA, Connecticut's written-policy requirement)
Your protection level depends on where you work and what kind of position you hold.